Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Letter to the Editor

Clinical significance of the discrepancy between radiological findings and biochemical responses in atezolizumab plus bevacizumab for hepatocellular carcinoma

Hideki Iwamoto, Shigeo Shimose, Takashi Niizeki, Hironori Koga, Takuji Torimura

Clin Mol Hepatol. 2022;28(3):575-579. Published online April 21, 2022

DOI: https://doi.org/10.3350/cmh.2022.0047

View: 2132 Download: 183 Citations: 3

5

Well differentiated hepatocellular carcinoma: Pathological diagnosis of needle biopsied Liver tissue

Jae Yeon Seok , Young Nyun Park

Clin Mol Hepatol. 2009;15(1):96-100. Published online March 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.1.96

View: 3356 Download: 21

1

PIVKA-II as a Serological Marker of Hepatocellular Carcinoma

Sook-Hyang Jeong

Clin Mol Hepatol. 2006;12(3):315-317. Published online January 1, 2000

View: 2237 Download: 23

3

Clinical Efficacy of Serum PIVKA-2 in the Diagnosis and Follow up after Treatment of Hepatocellular Carcinoma

Young Joon Yoon, M.D., Kwang-Hyub Han, M.D., Chul Kim, M.D., Chae Yoon Chon, M.D., Young Myoung Moon, M.D., Chang Hoon Han, M.D., Hye Jin Choi, M.D., Yong Soo Kim, M.D., Jae Yong Han, M.D. and Hyon Suk Kim, M.D.†

Clin Mol Hepatol. 2002;8(4):465-471. Published online January 1, 1970

View: 2841 Download: 25

Clinical Implication of Automatically Analysed AFP - L3 and PIVKA - 2 in the Diagnosis of Hepatocellular Carcinoma

Cheol Kim, M.D.*, Kwang Hyub Han, M.D.*, Yong Han Paik, M.D.*, Kun Hoon Song, M.D.*, Jae Yeon Jeong, M.D.*, Jeong Youp Park, M.D.*, Young Soo Park, M.D.*, Hyun Woong Lee, M.D.*, Tae Joo Jeon, M.D.*, Jae Yong Han, M.D.*, Kwan Sik Lee, M.D.*, Chae Yoon Chon, M.D.*, Young Myoung Moon, M.D.*, Kyoung Rhyul Lee, M.D.† , and Hyon Suk Kim, M.D.†

Clin Mol Hepatol. 2001;7(4):467-474. Published online January 1, 1970

View: 2535 Download: 25

Clinical Usefulness of PIVKA-II and Lens Culinaris Agglutinin-A Reactive Alpha-fetoprotein(AFP-L3) for the Diagnosis of Hepatocellular Carcinoma

B.H. Byun, Y.M. Park, S.H. Bae, J.Y. Choi, K.Y. Sung, S.H. Cho, N.I. Hahn, J.M. Yang, S.O. Choi, S.B. Cha, K.W. Chung, H.S. Sun, D.H. Park, B.S. Kim

Clin Mol Hepatol. 2000;6(2):205-214. Published online January 1, 2000

View: 2309 Download: 32

1 |

Viewed By 4201	Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease
Viewed By 2796	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Viewed By 2556	Recent updates on the management of autoimmune hepatitis
Viewed By 2523	Management of refractory ascites
Viewed By 2477	The independent effect of exercise on biopsy proven non-alcoholic fatty liver disease: A systematic review

Cited By 100	KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Cited By 44	From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
Cited By 42	Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
Cited By 40	Obesity and the risk of primary liver cancer: A systematic review and meta-analysis
Cited By 38	The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future

Search